“Serum of COVID-19 Patients Induces Endothelial Cell Dysfunction through PAR-2: A Potential Therapeutic Target”

https://pubmed.ncbi.nlm.nih.gov/38117300

The serum of COVID-19 patients induces endothelial cell dysfunction through protease-activated receptor 2, suggesting a potential therapeutic target for mitigating endothelial dysfunction in COVID-19.